Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. The company is also developing ADP-A2AFP, which is in phase I clinical trials for hepatocellular carcinoma; and ADP-A2M4CD8, which is in phase I clinical trial for SPEAR T-cells focusing on treating patients with lung, gastroesophageal, head and neck, ovarian, and bladder cancers. It has a collaboration and license agreement with GSK; third party collaborations with Noile-Immune Biotech Inc., Alpine Immune Sciences, Inc., and National Center for Cancer Immune Therapy in Denmark; strategic alliance agreement with the MD Anderson Cancer Center; and co-development and co-commercialization agreement with Universal Cells, Inc. Adaptimmune Therapeutics plc also has a strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic T-cell therapies utilizing aß T-cell receptors. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Adaptimmune Therapeutics plc American Depositary Shares.
Adaptimmune Therapeutics plc American Depositary Shares business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Adaptimmune Therapeutics plc American Depositary Shares are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Adaptimmune Therapeutics plc American Depositary Shares , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Adaptimmune Therapeutics plc American Depositary Shares including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Adaptimmune Therapeutics plc American Depositary Shares and all latest updates of the company are provided.
The 2025 version of Adaptimmune Therapeutics plc American Depositary Shares report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
NA
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Adaptimmune Therapeutics plc American Depositary Shares- Key Facts
2.2 Adaptimmune Therapeutics plc American Depositary Shares- Geographic Locations
2.3 Adaptimmune Therapeutics plc American Depositary Shares- Subsidiaries and Affiliates
2.4 Adaptimmune Therapeutics plc American Depositary Shares- Business Divisions
2.5 Adaptimmune Therapeutics plc American Depositary Shares- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Adaptimmune Therapeutics plc American Depositary Shares Strategic Analysis Review
3.1 Adaptimmune Therapeutics plc American Depositary Shares- Key Strategies
3.2 Adaptimmune Therapeutics plc American Depositary Shares- Company Outlook Statement
3.3 Adaptimmune Therapeutics plc American Depositary Shares- SWOT Analysis
3.3.1 Adaptimmune Therapeutics plc American Depositary Shares- Key Strengths
3.3.2 Adaptimmune Therapeutics plc American Depositary Shares- Key Weaknesses
3.3.3 Adaptimmune Therapeutics plc American Depositary Shares- Potential Opportunities
3.3.4 Adaptimmune Therapeutics plc American Depositary Shares- Potential Threats
3.4 Adaptimmune Therapeutics plc American Depositary Shares- Key Competitors
4. Business Description of the Company
4.1 Adaptimmune Therapeutics plc American Depositary Shares- Business Overview
4.2 Adaptimmune Therapeutics plc American Depositary Shares- Operations by Segment
5 Products and Services Details
5.1 Adaptimmune Therapeutics plc American Depositary Shares- Key Products
5.2 Adaptimmune Therapeutics plc American Depositary Shares- Key Service Areas
5.3 Adaptimmune Therapeutics plc American Depositary Shares- Key Brands
6 Company Developments
6.1 Adaptimmune Therapeutics plc American Depositary Shares- Company History
6.2 Adaptimmune Therapeutics plc American Depositary Shares- Latest Developments
7 Financial Analysis
7.1 Adaptimmune Therapeutics plc American Depositary Shares- Income Statements
7.2 Adaptimmune Therapeutics plc American Depositary Shares- Balance Sheet
7.3 Adaptimmune Therapeutics plc American Depositary Shares- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Adaptimmune Therapeutics plc American Depositary Shares- Direct Competitors
8.2 Adaptimmune Therapeutics plc American Depositary Shares- Competitor Financial Ratios comparison
8.3 Adaptimmune Therapeutics plc American Depositary Shares- Competitor Stock Charts Comparison
8.4 Adaptimmune Therapeutics plc American Depositary Shares- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
NA
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
